1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Oxidised IL-33 drives COPD epithelial pathogenesis via ST2-independent RAGE/EGFR signalling complex
(
- Contribution to journal › Article
-
Mark
Airway hyperresponsiveness reflects corticosteroid-sensitive mast cell involvement across asthma phenotypes
(
- Contribution to journal › Article
- 2022
-
Mark
Mucosal cryobiopsies : a new method for studying airway pathology in asthma
(
- Contribution to journal › Article
- 2021
-
Mark
RORγt inhibitors block both IL-17 and IL-22 conferring a potential advantage over anti-IL-17 alone to treat severe asthma
(
- Contribution to journal › Article
- 2020
-
Mark
Eosinophils, basophils, and type 2 immune microenvironments in COPD-affected lung tissue
(
- Contribution to journal › Article
- 2019
-
Mark
IL-33 blockade affects mediators of persistence and exacerbation in a model of chronic airway inflammation
(
- Contribution to journal › Article
-
Mark
Bronchoscopic mucosal cryobiopsies as a method for studying airway disease
(
- Contribution to journal › Article
- 2018
-
Mark
Interleukin-33 is activated by allergen- and necrosis-associated proteolytic activities to regulate its alarmin activity during epithelial damage
(
- Contribution to journal › Article
- 2015
-
Mark
IL-17A is Elevated in End-stage COPD and Contributes to Cigarette Smoke-induced Lymphoid Neogenesis.
(
- Contribution to journal › Article